rs200306870
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002025.4(AFF2):c.1121C>A(p.Ser374Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000312 in 1,199,259 control chromosomes in the GnomAD database, including 2 homozygotes. There are 125 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002025.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFF2 | NM_002025.4 | c.1121C>A | p.Ser374Tyr | missense_variant | 5/21 | ENST00000370460.7 | NP_002016.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFF2 | ENST00000370460.7 | c.1121C>A | p.Ser374Tyr | missense_variant | 5/21 | 5 | NM_002025.4 | ENSP00000359489.2 |
Frequencies
GnomAD3 genomes AF: 0.000314 AC: 35AN: 111507Hom.: 1 Cov.: 22 AF XY: 0.000356 AC XY: 12AN XY: 33671
GnomAD3 exomes AF: 0.000882 AC: 161AN: 182529Hom.: 0 AF XY: 0.000820 AC XY: 55AN XY: 67081
GnomAD4 exome AF: 0.000312 AC: 339AN: 1087698Hom.: 1 Cov.: 26 AF XY: 0.000319 AC XY: 113AN XY: 353926
GnomAD4 genome AF: 0.000314 AC: 35AN: 111561Hom.: 1 Cov.: 22 AF XY: 0.000356 AC XY: 12AN XY: 33735
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 05, 2017 | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 16, 2015 | - - |
AFF2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 12, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at